New nasal spray delivery could finally pop ear troubles away
NCT ID NCT05275686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new nasal spray system that delivers fluticasone deeper into the nose can relieve Eustachian tube dysfunction (ETD) — a condition causing ear pressure, popping, and muffled hearing. About 80 adults with chronic ETD will receive either the active spray or a placebo. The goal is to see if this improved delivery method works better than standard sprays.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC EUSTACHIAN TUBE DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
-
Indiana University
RECRUITINGIndianapolis, Indiana, 46202, United States
-
Ochsner Health System
RECRUITINGNew Orleans, Louisiana, 70121, United States
-
Sacramento Ear, Nose & Throat
RECRUITINGSacramento, California, 95661, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear drops after tube surgery: do they prevent blockage?
- Ear injury diagnosis showdown: which grading system wins?
- Easing the squeeze: new study aims to reduce ear pain in oxygen chambers
- Virtual reality could replace pills for pain during ENT procedures
- Could a simple device ease stuffy ears and face pain without drugs?
- Breathing technique may ease ear issues in teens exposed to smoke